These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9723127

  • 1. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
    Fukuda M, Takazawa S, Nakagome K, Iwanami A, Hata A, Kasai K, Hiramatsu K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
    [Abstract] [Full Text] [Related]

  • 2. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May 26; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA.
    Psychopharmacol Bull; 1998 May 26; 34(2):191-5. PubMed ID: 9640999
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL, Curtis GC, Cameron OG.
    J Psychiatr Res; 1996 May 26; 30(2):79-93. PubMed ID: 8816303
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct 26; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 6. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Klein E, Zinder O, Colin V, Zilberman I, Levy N, Greenberg A, Lenox RH.
    Acta Psychiatr Scand; 1995 Dec 26; 92(6):399-408. PubMed ID: 8837965
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
    Curtis GC, Abelson JL, Gold PW.
    Biol Psychiatry; 1997 Jan 01; 41(1):76-85. PubMed ID: 8988798
    [Abstract] [Full Text] [Related]

  • 8. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    J Clin Psychopharmacol; 2006 Oct 01; 26(5):519-23. PubMed ID: 16974197
    [Abstract] [Full Text] [Related]

  • 9. [The efficacy of alprazolam in the therapy of panic disorders].
    Diukova GM, Vorob'eva OV, Petrova EP, Smirnov SV, Tumalaeva ZN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995 Oct 01; 95(4):9-13. PubMed ID: 8533521
    [Abstract] [Full Text] [Related]

  • 10. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    Depress Anxiety; 2008 Oct 01; 25(8):E18-26. PubMed ID: 17960759
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy.
    Brambilla F, Bellodi L, Perna G.
    Psychiatry Res; 1999 Dec 13; 89(1):21-7. PubMed ID: 10643874
    [Abstract] [Full Text] [Related]

  • 12. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
    Bond AJ, Curran HV, Bruce MS, O'Sullivan G, Shine P.
    J Affect Disord; 1995 Dec 13; 35(3):117-23. PubMed ID: 8749839
    [Abstract] [Full Text] [Related]

  • 13. Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder.
    Shioiri T, Kita N, Takahashi S.
    Int Clin Psychopharmacol; 1996 Jun 13; 11(2):149-52. PubMed ID: 8803653
    [No Abstract] [Full Text] [Related]

  • 14. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
    Cowley DS, Roy-Byrne PP, Radant A, Ritchie JC, Greenblatt DJ, Nemeroff CB, Hommer DW.
    Neuropsychopharmacology; 1995 Apr 13; 12(2):147-57. PubMed ID: 7779243
    [Abstract] [Full Text] [Related]

  • 15. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV, Sheehan KH, Raj BA.
    Psychopharmacol Bull; 2007 Apr 13; 40(2):63-81. PubMed ID: 17514187
    [Abstract] [Full Text] [Related]

  • 16. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Arch Gen Psychiatry; 1993 Sep 13; 50(9):715-22. PubMed ID: 8357297
    [Abstract] [Full Text] [Related]

  • 17. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V, Uhlenhuth EH.
    Anxiety; 1996 Sep 13; 2(2):95-8. PubMed ID: 9160608
    [No Abstract] [Full Text] [Related]

  • 18. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1998 Dec 13; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam-induced panic disorder.
    Bashir A, Swartz C.
    J Am Board Fam Pract; 2002 Dec 13; 15(1):69-72. PubMed ID: 11841142
    [No Abstract] [Full Text] [Related]

  • 20. Psychoimmunoendocrine aspects of panic disorder.
    Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P.
    Neuropsychobiology; 1992 Dec 13; 26(1-2):12-22. PubMed ID: 1335559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.